| AbbVie AG - Alphagan, Augentropfen |
| 54605 | | 01 | | Alphagan | | Augentropfen | | S01EA05 | | Brimonidin | | 10.12.1998 | | |
|
| Composition |
| brimonidini tartras 2 mg corresp. brimonidinum 1.3 mg, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, poly(alcohol vinylicus), benzalkonii chloridum 50 µg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Collyre | | | | | | | | Principe actif | Concentr. |
|---|
| Brimonidine Tartrate | 2 mg/ml correspond Brimonidine 1.3 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Brimonidini Tartras | 2 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Citrique Monohydre | | | Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | | Aqua Purificata | | | Benzalkonium Chlorure | 50 µg/ml | | Sodium Chlorure | | | Natrii Citras Dihydricus | | | Poly(Alcohol Vinylicus) | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 013 | 5 ml | 7.92 | 17.85 | B | LS | Non | | 021 | 3 x 5 ml | 20.24 | 38.45 | B | LS | Non |
|
